Prior Information Notice (PIN) for an innovation partnership to evaluate Artificial Intelligence (AI) developed for breast cancer detection in breast screening, for use in symptomatic setting

Descriptions

The Royal Marsden NHS Foundation Trust (RM), working as part of a RM Partners (cancer alliance for north west and south west London) funded programme is seeking to create an innovation partnership to support a clinical research evaluation of an Artificial Intelligence (AI) tool developed for diagnosis of breast cancer on mammography images acquired in breast screening, in a retrospective study of use on images acquired in the symptomatic breast clinic. This procurement is to partner with an AI vendor to demonstrate performance of their AI tool developed for use in breast screening, in the context of the symptomatic breast clinic, using retrospective data. Further information, including details of how to respond and submit an expression of interest as part of Pre-Market Engagement, can be found at the end of this Notice.